Where is Novobac located?

Novobac is headquartered in Changsha, China.

Is Novobac a funded company?

Novobac is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Novobac rank among its competitors?

Novobac ranks 258th amongst 258 active competitors, of which 34 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Amoeba, which secured $7.73M in Mar, 2026.

Who are the top competitors of Novobac?

Novobac's top competitors include Ginkgo Bioworks, Indigo and Ascribe Bioscience. Among them, Amoeba secured the most recent funding round in March, 2026.

Novobac - 2026 Company Profile & Competitors

Novobac is an unfunded company based in Changsha (China), founded in 2020. It operates as a Provider of microbes-based crop protection solutions for farmers. Novobac has not raised any funding yet. The company has 258 active competitors, including 34 funded and 14 that have exited. Its top competitors include companies like Ginkgo Bioworks, Indigo and Ascribe Bioscience.

Key Metrics

Founded Year

2020

Location

Changsha, China

Stage

Unfunded

Ranked

258^th among 258 active competitors

Similar Companies

Indigo & 132 more

View Novobac's full profile

Novobac has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Novobac include Ginkgo Bioworks, Indigo and Ascribe Bioscience. Here is the list of Top 10 competitors of Novobac, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Ginkgo Bioworks 2008, Boston (United States), Public	Autonomous labs for biotechnology, empowering scientists to design the living world	$796M	Viking Global Investors, T. Rowe Price & 53 others	81/100
2nd	Indigo 2013, Boston (United States), Series G	Provider of biological and sustainability solutions for the agriculture industry	$1.4B	Flagship Pioneering, Baillie Gifford & 26 others	77/100
3rd	Ascribe Bioscience 2017, Ithaca (United States), Series B	Developer of natural crop protection products using soil microbiome molecules	$20.7M	The Yield Lab, Acre Venture Partners & 9 others	56/100
4th	Rizobacter 1983, Pergamino (Argentina), Acquired	Agricultural biosolutions company researching, developing, and commercializing innovative solutions for crop growth	-	Banco Galicia, Santander & 2 others	52/100
5th	AgBiome 2012, Raleigh (United States), Series D	Biotechnology company leveraging advanced microbial research	$233M	Polaris Partners, Monsanto & 18 others	52/100
6th	Kan Biosys 2005, Pune (India), Seed	Provider of microbes-based diversified crop biological solutions	$1.02M	Associated Group, De Sangosse & 18 others	51/100
7th	Amoeba 2010, Chassieu (France), Late Stage	Greentech innovator: harnessing amoeba for biocontrol, cosmetics, and water treatment	-	XAnge, UI Investissement & 1 others	50/100
8th	Grow Indigo 2018, Mumbai (India), Series B	Provider of biological products and carbon solutions for sustainable agriculture	$24M	Indigo, Mahyco & 2 others	49/100
9th	Pluton Biosciences 2017, St. Louis (United States), Series A	Provider of assay-based microbial research services	$24.2M	RA Capital Management, Illumina Ventures ... & 14 others	48/100
10th	Biofactor 2019, Hyderabad (India), Unfunded	Provider of microbes based biological solutions	-	-	47/100
258th	Novobac 2020, Changsha (China), Unfunded	Provider of microbes-based crop protection solutions for farmers	-	-	16/100